XTRA:BAYNPharmaceuticals
Is Bayer (XTRA:BAYN) Cheap After Its Clinical Trial Partnerships?
Bayer (XTRA:BAYN) is drawing fresh investor attention after announcing multi institution partnerships with Henry Ford Health and the University of Colorado Anschutz, UCHealth and Children’s Hospital Colorado to expand and speed up clinical trials.
See our latest analysis for Bayer.
Bayer’s recent clinical trial alliances arrive as momentum in the stock has picked up, with a 30 day share price return of 28.07% and a year to date share price return of 27.53%. The 1 year total shareholder return...